Sangel Capital Management Co., Ltd. is a venture capital investment firm established in 2010 in Shengzhen. Sangle Capital provides venture capital and business finance to support high-tech enterprises in China and western countries. The company seeks to invest innovative emerging-market enterprises in sectors including: biomedicine, medical devices, healthcare and bio-tech.
Sangel Capital has set Sage-Angel incubator and Sangel funds and been managing more than 50 projects. In July, 2015, Sangle Capital Management Co., Ltd. established its first international subsidiary—Sangel Capital Corp. (US) in Chicago, USA. This year, Sangel Capital Management Co., Ltd. won "China Outstanding Venture Capital Institution in Next Generation Award".
Shenzhen Beijing Shanghai Chicago
A Personalized Biomedical Technology
Biomedicine in China increased by 100 times in recent 15 years.